Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2025-12-25 @ 2:09 AM
NCT ID:
NCT01543360
Eligibility Criteria:
Inclusion Criteria:
* The patient must have given his/her informed and signed consent
* The patient must be insured or beneficiary of a health insurance plan
* The patient is available for 24 hours of follow-up
* Patient requiring the establishment of a central venous catheter
Exclusion Criteria:
* The patient is in an exclusion period determined by a previous study
* The patient is under judicial protection, under tutorship or curatorship
* The patient refuses to sign the consent
* It is impossible to correctly inform the patient
* The patient is pregnant, parturient, or breastfeeding
* Patient has a body mass index \< 15 or \> 40
* Congenital or acquired anatomical deformity (radiation therapy, trauma, surgery) of the axillary and/or subclavian regions
* Bleeding disorder (platelets \< 50,000, prothrombine \< 50%, activated cephaline time \> 2 times the control value)
* Severe hypoxemia defined by a ratio PaO2 / FIO2 \< 100
* Infection of the puncture area
* Known thrombosis of the subclavian or axillary veins
* Scheduled length of hospitalization less than 24 hours
* Agitated or non-cooperative patient
* The patient has already been included in this study
* subclavian and axillary veins are not simultaneously echogenic on one or both sides (left and right).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01543360
Study Brief:
Protocol Section:
NCT01543360